Ra Medical Systems, Inc.
RMED · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $420 | – | $14 | $22 |
| % Growth | – | – | -36.4% | – |
| Cost of Goods Sold | $42 | – | $161 | $1,560 |
| Gross Profit | $378 | – | -$147 | -$1,538 |
| % Margin | 90% | – | -1,050% | -6,990.9% |
| R&D Expenses | $272 | – | $6,392 | $12,253 |
| G&A Expenses | $0 | – | $2,233 | $0 |
| SG&A Expenses | $11,349 | – | $16,250 | $15,475 |
| Sales & Mktg Exp. | $0 | – | $1,252 | $0 |
| Other Operating Expenses | $0 | – | $99 | $0 |
| Operating Expenses | $11,621 | – | $22,642 | $27,728 |
| Operating Income | -$11,243 | – | -$26,961 | -$29,266 |
| % Margin | -2,676.9% | – | -192,578.6% | -133,027.3% |
| Other Income/Exp. Net | -$2,259 | – | $3 | $2,009 |
| Pre-Tax Income | -$13,502 | – | -$26,862 | -$27,257 |
| Tax Expense | $3,141 | – | $3 | $4 |
| Net Income | -$21,801 | – | -$26,865 | -$27,261 |
| % Margin | -5,190.7% | – | -191,892.9% | -123,913.6% |
| EPS | -6.68 | – | -25.98 | -269.91 |
| % Growth | – | – | 90.4% | – |
| EPS Diluted | -6.68 | – | -25.98 | -269.91 |
| Weighted Avg Shares Out | 3,264 | – | 1,034 | 101 |
| Weighted Avg Shares Out Dil | 3,264 | – | 1,034 | 101 |
| Supplemental Information | – | – | – | – |
| Interest Income | $81 | – | $0 | $0 |
| Interest Expense | -$91 | – | $3,078 | $0 |
| Depreciation & Amortization | $0 | – | $8,765 | $1,565 |
| EBITDA | -$11,243 | – | -$18,196 | -$29,266 |
| % Margin | -2,676.9% | – | -129,971.4% | -133,027.3% |